Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 3/2019

24.08.2018 | Other Articles

Sinonasal Metastatic Renal Cell Carcinoma: A Report of Two Cases with Varied Presentation and a Review of Literature

verfasst von: Pooja Dalakoti, Kailesh Pujary, Balakrishnan Ramaswamy

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Sonderheft 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Renal cell carcinoma is usually slow growing with delayed vague symptoms and may not be detected until an advanced stage. In only 9% of the cases the classical triad of “haematuria, costovertebral pain and abdominal mass” is seen. Less commonly, sinonasal metastasis may also be the presenting feature of RCC. So, in any case of sinonasal mass, possibility of metastasis from renal malignancy should be considered. Sinonasal metastasis from renal malignancy can occur even several years after the primary is treated with nephrectomy. In sinonasal region maxillary sinus is the most commonly affected. Isolated metastasis to the nose is extremely rare. Malignancies from various other sites of the body can also metastasize to sinonasal region. Epistaxis is the most common symptom. This is because of vascular stroma of the metastatic deposit. A 45 year old male with history of right nephrectomy 1 year back presented with intractable epistaxis. A 66 year old male presented with profuse epistaxis without any history of previous malignancies. Both the cases were evaluated resulting to the diagnosis of sinonasal metastasis from Renal Cell carcinoma. In the first case, metastasis occurred 1 year post surgery whereas in second case sinonasal metastasis was the presenting feature of Renal Cell carcinoma. Epistaxis is the most common symptom. This is because of vascular stroma of this metastatic deposit. In renal cancer, symptoms of metastasis often precede the symptoms of primary tumor.
Literatur
1.
Zurück zum Zitat Nayak DR, Pujary K, Ramnani S, Shetty C, Parul P (2006) Metastatic renal cell carcinoma presenting with epistaxis. Indian J Otolaryngol Head Neck Surg 58(4):406–408CrossRef Nayak DR, Pujary K, Ramnani S, Shetty C, Parul P (2006) Metastatic renal cell carcinoma presenting with epistaxis. Indian J Otolaryngol Head Neck Surg 58(4):406–408CrossRef
2.
Zurück zum Zitat Gottlieb MD, Roland JT (1998) Paradoxical spread of renal cell carcinoma to the head and neck. Laryngoscope 108(9):1301–1305CrossRef Gottlieb MD, Roland JT (1998) Paradoxical spread of renal cell carcinoma to the head and neck. Laryngoscope 108(9):1301–1305CrossRef
4.
Zurück zum Zitat Abraham GP, Cherian T, Mahadevan P, Avinash TS, George D, Manuel E (2016) Detailed study of survival of patients with renal cell carcinoma in India. Indian J Cancer 53(4):572CrossRef Abraham GP, Cherian T, Mahadevan P, Avinash TS, George D, Manuel E (2016) Detailed study of survival of patients with renal cell carcinoma in India. Indian J Cancer 53(4):572CrossRef
5.
Zurück zum Zitat Nahum AM, Bailey BJ (1963) Malignant tumors metastatic to the paranasal sinuses: case report and review of the literature. Laryngoscope 73(7):942–953CrossRef Nahum AM, Bailey BJ (1963) Malignant tumors metastatic to the paranasal sinuses: case report and review of the literature. Laryngoscope 73(7):942–953CrossRef
6.
Zurück zum Zitat Simo R, Sykes AJ, Hargreaves SP, Axon PR, Birzgalis AR, Slevin NJ, Farrington WT (2000) Metastatic renal cell carcinoma to the nose and paranasal sinuses. Head Neck: J Sci Spec Head Neck 22(7):722–727CrossRef Simo R, Sykes AJ, Hargreaves SP, Axon PR, Birzgalis AR, Slevin NJ, Farrington WT (2000) Metastatic renal cell carcinoma to the nose and paranasal sinuses. Head Neck: J Sci Spec Head Neck 22(7):722–727CrossRef
7.
Zurück zum Zitat McNichols DW, Segura JW, DeWeerd JH (1981) Renal cell carcinoma: long-term survival and late recurrence. J Urol 126(1):17–23CrossRef McNichols DW, Segura JW, DeWeerd JH (1981) Renal cell carcinoma: long-term survival and late recurrence. J Urol 126(1):17–23CrossRef
8.
Zurück zum Zitat Godley PA, Stinchcombe TE (1999) Renal cell carcinoma. Curr Opin Oncol 11:213–217CrossRef Godley PA, Stinchcombe TE (1999) Renal cell carcinoma. Curr Opin Oncol 11:213–217CrossRef
9.
Zurück zum Zitat Som PM, Norton KI, Shugar JM, Reede DL, Norton L, Biller HF, Som ML (1987) Metastatic hypernephroma to the head and neck. Am J Neuroradiol 8(6):1103–1106PubMed Som PM, Norton KI, Shugar JM, Reede DL, Norton L, Biller HF, Som ML (1987) Metastatic hypernephroma to the head and neck. Am J Neuroradiol 8(6):1103–1106PubMed
10.
Zurück zum Zitat Boles R, Cerny J (1971) Head and neck metastases from renal carcinomas. Mich Med 70(16):616–618PubMed Boles R, Cerny J (1971) Head and neck metastases from renal carcinomas. Mich Med 70(16):616–618PubMed
11.
Zurück zum Zitat Sgouras ND, Gamatsi IE, Porfyris EA, Lekka JA, Harkiolakis GC, Nikolopoulou SM, Valvis PJ (1995) An unusual presentation of a metastatic hypernephroma to the frontonasal region. Ann Plast Surg 34(6):653–656CrossRef Sgouras ND, Gamatsi IE, Porfyris EA, Lekka JA, Harkiolakis GC, Nikolopoulou SM, Valvis PJ (1995) An unusual presentation of a metastatic hypernephroma to the frontonasal region. Ann Plast Surg 34(6):653–656CrossRef
12.
Zurück zum Zitat Sountoulides P, Metaxa L, Cindolo L (2011) Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports. J Med Case Rep 5(1):429CrossRef Sountoulides P, Metaxa L, Cindolo L (2011) Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports. J Med Case Rep 5(1):429CrossRef
13.
Zurück zum Zitat Matsumoto Y, Yanagihara N (1982) Renal clear cell carcinoma metastatic to the nose and paranasal sinuses. Laryngoscope 92(10):1190–1193CrossRef Matsumoto Y, Yanagihara N (1982) Renal clear cell carcinoma metastatic to the nose and paranasal sinuses. Laryngoscope 92(10):1190–1193CrossRef
14.
Zurück zum Zitat Airoldi M, Succo G, Valente G, Cavalot A, Gabriele P, Bumma C (1995) Head and neck metastases of renal cancer after nephrectomy: a report of 2 cases. Tumori J 81(3):213–214CrossRef Airoldi M, Succo G, Valente G, Cavalot A, Gabriele P, Bumma C (1995) Head and neck metastases of renal cancer after nephrectomy: a report of 2 cases. Tumori J 81(3):213–214CrossRef
15.
Zurück zum Zitat Pritchyk KM, Schiff BA, Newkirk KA, Krowiak E, Deeb ZE (2002) Metastatic renal cell carcinoma to the head and neck. Laryngoscope 112:1598–1601CrossRef Pritchyk KM, Schiff BA, Newkirk KA, Krowiak E, Deeb ZE (2002) Metastatic renal cell carcinoma to the head and neck. Laryngoscope 112:1598–1601CrossRef
16.
Zurück zum Zitat Lang EE, Patil N, Walsh RM, Leader M, Walsh MA (2003) A case of renal cell carcinoma metastatic to the nose and tongue. Ear Nose Throat J 82(5):382CrossRef Lang EE, Patil N, Walsh RM, Leader M, Walsh MA (2003) A case of renal cell carcinoma metastatic to the nose and tongue. Ear Nose Throat J 82(5):382CrossRef
17.
Zurück zum Zitat Duque-Fisher CS, Casiano R, Vélez-Hoyos A, Londoño-Bustamente AF (2009) Metastasis to the sinonasal region. Acta Otorrinolaringol Esp 60(6):428–431CrossRef Duque-Fisher CS, Casiano R, Vélez-Hoyos A, Londoño-Bustamente AF (2009) Metastasis to the sinonasal region. Acta Otorrinolaringol Esp 60(6):428–431CrossRef
18.
Zurück zum Zitat Nahum AM, Bailey BJ (1963) Malignant tumors metastatic to the paranasal sinuses: case report and review of the literature. Laryngoscope 73(7):942–953CrossRef Nahum AM, Bailey BJ (1963) Malignant tumors metastatic to the paranasal sinuses: case report and review of the literature. Laryngoscope 73(7):942–953CrossRef
19.
Zurück zum Zitat Bernstein JM, Montgomer WW, Balogh K (1966) Metastatic tumors to the maxilla, nose, and paranasal sinuses. Laryngoscope 76(4):621–650CrossRef Bernstein JM, Montgomer WW, Balogh K (1966) Metastatic tumors to the maxilla, nose, and paranasal sinuses. Laryngoscope 76(4):621–650CrossRef
20.
Zurück zum Zitat Turner KJ, Moore JW, Jones A, Taylor CF, Cuthbert-Heavens D, Han C, Leek RD, Gatter KC, Maxwell PH, Ratcliffe PJ, Cranston D (2002) Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel–Lindau gene mutation. Can Res 62(10):2957–2961 Turner KJ, Moore JW, Jones A, Taylor CF, Cuthbert-Heavens D, Han C, Leek RD, Gatter KC, Maxwell PH, Ratcliffe PJ, Cranston D (2002) Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel–Lindau gene mutation. Can Res 62(10):2957–2961
21.
Zurück zum Zitat Terada N, Hiruma K, Suzuki M, Numata T, Konno A (1998) Metastasis of renal cell cancer to the ethmoid sinus. Acta Oto-Laryngol 118(537):82–86CrossRef Terada N, Hiruma K, Suzuki M, Numata T, Konno A (1998) Metastasis of renal cell cancer to the ethmoid sinus. Acta Oto-Laryngol 118(537):82–86CrossRef
22.
Zurück zum Zitat Ziari M, Shen S, Amato RJ et al (2006) Metastatic renal cell carcinoma to the nose and ethmoid sinus. Urology 67:199CrossRef Ziari M, Shen S, Amato RJ et al (2006) Metastatic renal cell carcinoma to the nose and ethmoid sinus. Urology 67:199CrossRef
23.
Zurück zum Zitat Jonasch E, Gao J, Rathmell WK (2014) Renal Cell Carcinoma. BMJ 349:g4797CrossRef Jonasch E, Gao J, Rathmell WK (2014) Renal Cell Carcinoma. BMJ 349:g4797CrossRef
24.
Zurück zum Zitat Yamazaki K, Sakamoto M, Ohta T, Kanai Y, Ohki M, Hirohashi S (2003) Overexpression of KIT in chromophobe renal cell carcinoma. Oncogene 22(6):847CrossRef Yamazaki K, Sakamoto M, Ohta T, Kanai Y, Ohki M, Hirohashi S (2003) Overexpression of KIT in chromophobe renal cell carcinoma. Oncogene 22(6):847CrossRef
25.
Zurück zum Zitat Moch H, Humphrey P, Ulbright TM, Reuter VE (2016) WHO classification of tumours of the urinary system and male genital organs, 4th edn. IARC Press, Lyon Moch H, Humphrey P, Ulbright TM, Reuter VE (2016) WHO classification of tumours of the urinary system and male genital organs, 4th edn. IARC Press, Lyon
26.
Zurück zum Zitat Jung K, Lein M, Laube C, Lichtinghagen R (2001) Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood. Clin Chim Acta 314(1–2):241–244CrossRef Jung K, Lein M, Laube C, Lichtinghagen R (2001) Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood. Clin Chim Acta 314(1–2):241–244CrossRef
27.
Zurück zum Zitat Mikami S, Oya M, Mizuno R, Kosaka T, Ishida M, Kuroda N, Nagashima Y, Katsube KI, Okada Y (2016) Recent advances in renal cell carcinoma from a pathological point of view. Pathol Int 66(9):481–490CrossRef Mikami S, Oya M, Mizuno R, Kosaka T, Ishida M, Kuroda N, Nagashima Y, Katsube KI, Okada Y (2016) Recent advances in renal cell carcinoma from a pathological point of view. Pathol Int 66(9):481–490CrossRef
28.
Zurück zum Zitat Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, Ginsberg MS, Kim ST, Baum CM, DePrimo SE, Li JZ (2006) Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 24(1):16–24CrossRef Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, Ginsberg MS, Kim ST, Baum CM, DePrimo SE, Li JZ (2006) Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 24(1):16–24CrossRef
29.
Zurück zum Zitat Pantuck AJ, Zisman A, Belldegrun A (2001) Gene and immune therapy for renal cell carcinoma. Int J Urol 8(7):S1–S4CrossRef Pantuck AJ, Zisman A, Belldegrun A (2001) Gene and immune therapy for renal cell carcinoma. Int J Urol 8(7):S1–S4CrossRef
30.
Zurück zum Zitat Pritchyk KM, Schiff BA, Newkirk KA, Krowiak E, Deeb ZE (2002) Metastatic renal cell carcinoma to the head and neck. Laryngoscope 112(9):1598–1602CrossRef Pritchyk KM, Schiff BA, Newkirk KA, Krowiak E, Deeb ZE (2002) Metastatic renal cell carcinoma to the head and neck. Laryngoscope 112(9):1598–1602CrossRef
31.
Zurück zum Zitat Ziari M, Shen S, Amato RJ, Teh BS (2006) Metastatic renal cell carcinoma to the nose and ethmoid sinus. Urology 67(1):199CrossRef Ziari M, Shen S, Amato RJ, Teh BS (2006) Metastatic renal cell carcinoma to the nose and ethmoid sinus. Urology 67(1):199CrossRef
32.
Zurück zum Zitat Yagoda A, Bander NH (1989) Failure of cytotoxic chemotherapy, 1983–1988, and the emerging role of monoclonal antibodies for renal cancer. Urol Int 44(6):338–345CrossRef Yagoda A, Bander NH (1989) Failure of cytotoxic chemotherapy, 1983–1988, and the emerging role of monoclonal antibodies for renal cancer. Urol Int 44(6):338–345CrossRef
33.
Zurück zum Zitat Harris DT (1983) Hormonal therapy and chemotherapy of renal-cell carcinoma. Semin Oncol 10(4):422–430PubMed Harris DT (1983) Hormonal therapy and chemotherapy of renal-cell carcinoma. Semin Oncol 10(4):422–430PubMed
34.
Zurück zum Zitat Horoszewicz JS, Murphy GP (1989) An assessment of the current use of human interferons in therapy of urological cancers. J Urol 142(5):1173–1180CrossRef Horoszewicz JS, Murphy GP (1989) An assessment of the current use of human interferons in therapy of urological cancers. J Urol 142(5):1173–1180CrossRef
35.
Zurück zum Zitat Ritchie A, Griffiths G, Parmar M, Fossa SD, Selby PJ, Cornbleet MA, Sibley G, Mead GM, Kaye S, Owen JR, Oliver RT (1999) Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Lancet 353(9146):14–17CrossRef Ritchie A, Griffiths G, Parmar M, Fossa SD, Selby PJ, Cornbleet MA, Sibley G, Mead GM, Kaye S, Owen JR, Oliver RT (1999) Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Lancet 353(9146):14–17CrossRef
36.
Zurück zum Zitat Pyrhönen S, Salminen E, Ruutu M, Lehtonen T, Nurmi M, Tammela T, Juusela H, Rintala E, Hietanen P, Kellokumpu-Lehtinen PL (1999) Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer. J Clin Oncol 17(9):2859CrossRef Pyrhönen S, Salminen E, Ruutu M, Lehtonen T, Nurmi M, Tammela T, Juusela H, Rintala E, Hietanen P, Kellokumpu-Lehtinen PL (1999) Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer. J Clin Oncol 17(9):2859CrossRef
37.
Zurück zum Zitat Rosenberg SA, Yang JC, White DE, Steinberg SM (1998) Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann Surg 228(3):307CrossRef Rosenberg SA, Yang JC, White DE, Steinberg SM (1998) Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann Surg 228(3):307CrossRef
38.
Zurück zum Zitat Fisher RI, Rosenberg SA, Sznol M, Parkinson DR, Fyfe G (1997) High-dose aldesleukin in renal cell carcinoma: long-term survival update. Cancer J Sci Am 3:S70–S72PubMed Fisher RI, Rosenberg SA, Sznol M, Parkinson DR, Fyfe G (1997) High-dose aldesleukin in renal cell carcinoma: long-term survival update. Cancer J Sci Am 3:S70–S72PubMed
39.
Zurück zum Zitat Vogelzang N, Teh BS, Furge K, Teh BT (2003) Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics. Adv Cancer Res 89:157–181CrossRef Vogelzang N, Teh BS, Furge K, Teh BT (2003) Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics. Adv Cancer Res 89:157–181CrossRef
Metadaten
Titel
Sinonasal Metastatic Renal Cell Carcinoma: A Report of Two Cases with Varied Presentation and a Review of Literature
verfasst von
Pooja Dalakoti
Kailesh Pujary
Balakrishnan Ramaswamy
Publikationsdatum
24.08.2018
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe Sonderheft 3/2019
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-018-1475-4

Weitere Artikel der Sonderheft 3/2019

Indian Journal of Otolaryngology and Head & Neck Surgery 3/2019 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.